Neurophysiologic Biomarkers in Neuropsychiatric Disorders

Etiologic and Treatment Considerations de

,

Éditeur :

Springer


Paru le : 2024-11-19

eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
233,19

Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description

This book reviews neurophysiological biomarkers in neuropsychiatric disorders from the viewpoint of the 21st Century Cures Act, which encourages the use of biomarkers for a variety of purposes during drug development. It covers both traditional etiologic uses of biomarkers and the more recent Biomarkers, EndpointS, and other Tools (BEST) classification scheme used by the FDA, which permits biomarkers for purposes of susceptibility, diagnosis, monitoring, prognosis, pharmacodynamics/response, and safety. The first section of the book describes potential uses of neurophysiologic biomarkers. Subsequent sections focus on a wide range of conditions, including schizophrenia, autism spectrum disorder, Parkinson’s disease, and depression, as well as cross-diagnostic and translational uses, including monkey and rodent analogs. The purpose of the book is to help clinicians understand how neurophysiological biomarkers may be used to understand and manage clinical conditions; to help researchers to understand how biomarkers may be used translationally to test specific theories; and to help pharma investigators to understand how biomarkers can be used to accelerate treatment development.
Pages
831 pages
Collection
n.c
Parution
2024-11-19
Marque
Springer
EAN papier
9783031694905
EAN PDF
9783031694912

Informations sur l'ebook
Nombre pages copiables
8
Nombre pages imprimables
83
Taille du fichier
43612 Ko
Prix
233,19 €
EAN EPUB
9783031694912

Informations sur l'ebook
Nombre pages copiables
8
Nombre pages imprimables
83
Taille du fichier
65915 Ko
Prix
233,19 €

Suggestions personnalisées